We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Gut “Memory” May Explain Why IBD Flares Return

By LabMedica International staff writers
Posted on 28 Aug 2026

Inflammatory bowel diseases (IBD), including Crohn’s disease and ulcerative colitis, are characterized by recurring flare-ups that damage the intestinal mucosa and remain difficult to predict. More...

Although acute intestinal injury often precedes these conditions, the mechanisms that transform temporary damage into chronic inflammation are not fully understood. Clinicians also lack reliable markers to determine whether apparently healed tissue remains at risk. New findings show that lasting changes in the gut’s extracellular matrix can encode an inflammatory “memory” that alters stem cell fate long after symptoms have subsided.

Researchers at the Weizmann Institute of Science investigated whether short-lived intestinal inflammation leaves lasting imprints in the extracellular matrix (ECM), the protein-sugar scaffold surrounding epithelial cells. In mouse models of acute colitis, they tracked tissue architecture and ECM properties for more than a year after clinical recovery. The team also used miniature three-dimensional intestinal organoids grown from stem cells, along with single-cell RNA sequencing (scRNA-seq) resources and seven biopsies from patients with ulcerative colitis, to probe how ECM alterations influence epithelial differentiation.

The study identified collagen 18 as a key mediator of this inflammatory imprint. According to the authors, collagen 18 can trap signaling molecules within the ECM, disrupting pathways that normally direct stem cells to rebuild healthy epithelium and instead biasing them toward pro-inflammatory epithelial states. Silencing collagen 18 expression in mice prevented the ECM from sustaining irreversible damage and halted progression to chronic disease, supporting a causal role for ECM remodeling in persistent inflammation.

Even after the animals appeared to recover, the ECM remained less stiff, more porous, and disorganized at 80 and 400 days, revealing a long-lasting “memory” within the tissue microenvironment. Organoids grown on the disrupted ECM formed malformed sheets rather than normal crypt–villus structures, while transcriptomic profiling showed that the cells matured into inflammation-promoting epithelial states that recruit immune cells.

Published August 26, 2026, in Immunity, the findings suggest that the ECM acts as a “logistics hub” that stores and regulates signaling cues, with potential implications for predicting flare-prone regions and identifying therapeutic targets such as collagen 18.

“Growing stem cells as organoids within a disrupted extracellular matrix was enough to change their fate. Using a single-cell RNA sequencing database and seven biopsies from patients with ulcerative colitis, we found that these same pro-inflammatory epithelial cells also characterize inflamed regions in patients. These findings make it clear that the extracellular matrix plays a critical role in chronic inflammation and could potentially make it possible to predict which regions will develop inflammation or experience a future flare-up. More broadly, the new study reveals just how central the ECM is in creating a microenvironment, or niche, that supports stem cell regeneration,” said Dr. Moshe Biton of the Weizmann Institute of Science.

Related Links
Weizmann Institute of Science

 


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
New
Nucleic Acid Purification Instrument
QIAsymphony Connect
New
Gold Member
Serum Indices Control
Acusera Serum Indices Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Image: Graphical Abstract (Nagy, G.R., Munkácsy, G., Murmu, A. et al. Beyond the linear genome: how reference bias threatens preventive medicine and geroscience. GeroScience, 2026. https://doi.org/10.1007/s11357-026-02436-z)

Study Shows How Genome Reference Bias Can Mislead Preventive Testing

Whole-genome sequencing is expected to play a growing role in preventive and predictive medicine, but accurate interpretation remains a major diagnostic challenge. The approach requires comparing billions... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image: Natera\'s MCED assay analyzes cell-free DNA in blood to screen for multiple cancers (Image Credit: Adobe Stock)

Multi-Cancer Screening Blood Test Gains FDA Breakthrough Designation

Natera Inc.’s (Austin, TX, USA) multi-cancer early detection (MCED) assay has received Breakthrough Device designation (BDD) from the U.S. Food and Drug Administration (FDA). The assay analyzes cell-free... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.